Search research articles
Contact Us
Filters
Showing results (21-30 of 235) with videos related to
Page
of 24
Sort By:
Cancer Discovery
|
April 3, 2019
Wishing on a CAR: Understanding the Scope of Intrinsic T-cell Deficits in Patients with Cancer
Mark Leick, Marcela V Maus
Journal for Immunotherapy of Cancer
|
March 24, 2017
Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
Irene Scarfò, Marcela V Maus
Blood
|
March 12, 2026
When CAR T cells become the disease
Viktoria Blumenberg, Marcela V Maus
Blood Advances
|
December 10, 2024
Charting the course for CAR T-cell manufacturing
Magdi Elsallab, Marcela V Maus
Nature Biotechnology
|
June 5, 2019
Gene editing for immune cell therapies
Stefanie R Bailey, Marcela V Maus
Blood Cancer Discovery
|
August 26, 2022
CAR T Cells Contend with Myeloma in the Bone Marrow Microenvironment
Charlotte E Graham, Marcela V Maus
Cancer Journal (Sudbury, Mass.)
|
November 21, 2015
Chimeric Antigen Receptor T-Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity
Marcela V Maus, Daniel J Powell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2016
Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
Marcela V Maus, Carl H June
American Journal of Hematology
|
January 12, 2019
CAR-T cells beyond CD19, UnCAR-Ted territory
Mark B Leick, Marcela V Maus
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 15, 2025
Isolated oral CAR<sup>+</sup> T cell lymphoma after tisagenlecleucel
Mark B Leick, Marcela V Maus
Page
of 24
Search research articles
Search
Showing results (21-30 of 235) with videos related to
Sort By:
Page
of 24
Cancer Discovery
|
April 3, 2019
Wishing on a CAR: Understanding the Scope of Intrinsic T-cell Deficits in Patients with Cancer
Mark Leick, Marcela V Maus
Journal for Immunotherapy of Cancer
|
March 24, 2017
Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
Irene Scarfò, Marcela V Maus
Blood
|
March 12, 2026
When CAR T cells become the disease
Viktoria Blumenberg, Marcela V Maus
Blood Advances
|
December 10, 2024
Charting the course for CAR T-cell manufacturing
Magdi Elsallab, Marcela V Maus
Nature Biotechnology
|
June 5, 2019
Gene editing for immune cell therapies
Stefanie R Bailey, Marcela V Maus
Blood Cancer Discovery
|
August 26, 2022
CAR T Cells Contend with Myeloma in the Bone Marrow Microenvironment
Charlotte E Graham, Marcela V Maus
Cancer Journal (Sudbury, Mass.)
|
November 21, 2015
Chimeric Antigen Receptor T-Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity
Marcela V Maus, Daniel J Powell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2016
Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
Marcela V Maus, Carl H June
American Journal of Hematology
|
January 12, 2019
CAR-T cells beyond CD19, UnCAR-Ted territory
Mark B Leick, Marcela V Maus
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 15, 2025
Isolated oral CAR<sup>+</sup> T cell lymphoma after tisagenlecleucel
Mark B Leick, Marcela V Maus
Page
of 24